ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,064.20
      0.91%
      US Tech 100
      17,173.20
      1.85%
      Dow Jones
      38,225.66
      0.85%
      Brent Oil
      83.775
      0.17%
      Bitcoin
      59,727.09
      1.02%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Molecular Templates Inc (MTEM)

      7. Molecular Templates Inc (MTEM) News

      MTEM

      Molecular Templates (MTEM)

      Molecular Templates Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MTEM
      DateTimeSourceHeadlineSymbolCompany
      2:07PMiHub NewswireFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
      04/09/20248:11AMGlobeNewswire Inc.Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer PatienNASDAQ:MTEMMolecular Templates Inc
      03/29/20248:21AMGlobeNewswire Inc.Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
      03/28/20248:11AMGlobeNewswire Inc.Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase AgreementNASDAQ:MTEMMolecular Templates Inc
      03/04/20248:11AMGlobeNewswire Inc.Molecular Templates, Inc. Provides Interim UpdateNASDAQ:MTEMMolecular Templates Inc
      02/14/20248:39PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MTEMMolecular Templates Inc
      02/14/20244:45PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MTEMMolecular Templates Inc
      02/08/20245:55PMGlobeNewswire Inc.Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:MTEMMolecular Templates Inc
      01/25/20245:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
      01/25/20245:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
      01/25/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
      01/17/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MTEMMolecular Templates Inc
      11/13/20234:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MTEMMolecular Templates Inc
      11/13/20234:12PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MTEMMolecular Templates Inc
      11/13/20234:11PMGlobeNewswire Inc.Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
      11/02/20234:11PMGlobeNewswire Inc.Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid TumorsNASDAQ:MTEMMolecular Templates Inc
      11/01/20234:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
      11/01/20234:12PMGlobeNewswire Inc.Molecular Templates to Participate in Upcoming Investor ConferencesNASDAQ:MTEMMolecular Templates Inc
      10/31/20236:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
      10/31/20236:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
      10/31/20236:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
      10/31/20236:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
      10/31/20236:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
      10/31/20236:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
      10/27/20234:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MTEMMolecular Templates Inc
      10/06/20235:08PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
      09/28/20235:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MTEMMolecular Templates Inc
      09/28/20234:11PMGlobeNewswire Inc.Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical OfficerNASDAQ:MTEMMolecular Templates Inc
      09/12/20235:15PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MTEMMolecular Templates Inc
      09/12/20235:12PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MTEMMolecular Templates Inc
       Showing the most relevant articles for your search:NASDAQ:MTEM